Evidence map›Paper›PMID 35022055›Full record

ArticleGenome biology2022

The blooming of long-read sequencing reforms biomedical research.

Kin Fai Au

Abstract readEditorial
In one paragraph

Article in Genome biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kin Fai AuDepartment of Biomedical Informatics, The Ohio State University, Columbus, OH, 43210, USA. kinfai.au@osumc.edu.

Funding

Quantitative and function analysis platform for repetitive genes and gene isoforms in pluripotency regulation and differentiationsR01HG011469 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AU, KIN FAI · 2021 to 2024
$2.6M
Bioinformatics platform for Hybrid-Seq transcriptome data analysisR01HG008759 · NHGRI · UNIVERSITY OF IOWA · PI AU, KIN FAI · 2016 to 2020
$1.9M
Experimental and bioinformatics platform for epigenome analysis using nanopore sequencingR01GM136886 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AU, KIN FAI · 2021 to 2024
$1.7M
NHGRI NIH HHS R01 HG008759NHGRI NIH HHS R01 HG011469NIGMS NIH HHS R01 GM136886
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomedical ResearchHigh-Throughput Nucleotide SequencingSequence Analysis, DNA

Identifiers

PMID35022055
PMCPMC8756655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.